Drug intelligence / Profile preview

clonitazene

Development stage
Discontinued
Modality
Small Molecules
Administration
Oral, Subcutaneous (based On Animal Studies)
01

Overview

Clonitazene is a synthetic opioid analgesic belonging to the benzimidazole class of compounds known as nitazenes. It acts primarily as a mu-opioid receptor agonist and produces analgesic effects comparable to or slightly less potent than morphine in animal models. Clonitazene was developed in the mid-20th century but was never marketed due to its high potential for abuse and risk of respiratory depression. It is classified as an experimental and illicit substance with no accepted medical use. Clonitazene is structurally related to other nitazenes such as etonitazene and metonitazene, which are generally more potent[2][3][7]. The drug has been detected in illicit drug markets and is controlled under Schedule I regulations in several countries due to its abuse potential[4][5].

Other names
clobedolumclonitacenoclonitazenum
02

Targets

MOR (Mu opioid receptor)

Beyond the preview

Go deeper on clonitazene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clonitazene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call